Proceedings from the CIHLMU 2025 symposium: the role of artificial intelligence in health systems strengthening to achieve One Health [0.03%]
Martha Chipinduro,Patrícia Ramgi,Julieth Lalashowi et al.
Martha Chipinduro et al.
The development of Artificial Intelligence (AI) is rapidly advancing, and AI tools are being integrated into many aspects of daily life, including medical care and public health. The full extent to which AI related tools can be implemented ...
West African Policy Dialogue-impulse for better data: progress towards better analytics and better decisions [0.03%]
西非政策对话：推动更好的数据收集及更好分析与决策的进展
Gideon Kwarteng Acheampong,Fortress Yayra Aku,John Amuasi et al.
Gideon Kwarteng Acheampong et al.
In a context of increasing efforts towards the establishment of a Regional Health Data Hub for the African Region, the 2024 West African Policy Dialogue brought together researchers and policymakers from seven West African countries in a tw...
Correction: Respiratory virus surveillance in the post-pandemic era: challenges and opportunities for dashboard-based public health action [0.03%]
纠正：后疫情时代的呼吸系统病毒监测：基于仪表板的公共卫生行动面临的挑战与机遇
Adrienne Halley,Caroline Schneeberger,Foekje F Stelma et al.
Adrienne Halley et al.
Published Erratum
BMC proceedings. 2026 Apr 2;20(1):17. DOI:10.1186/s12919-026-00372-6 2026
Multimodal AI-driven analysis in breast and lung cancer: insights from the OPTIMA prototyping workshop [0.03%]
多模态AI驱动的乳腺癌和肺癌分析：OPTIMA原型设计研讨会的见解
Maryam Abdollahyan,Emanuela Gadaleta,Lewis G E James et al.
Maryam Abdollahyan et al.
This paper reports on insights from the OPTIMA (Optimal Treatment for Patients with Solid Tumours in Europe Through Artificial Intelligence) prototyping workshop held in Berlin from November 6 to November 8, 2024. Through integrated analysi...
Expert opinion on treatment patterns in metastatic colorectal cancer management in Eastern Europe [0.03%]
东欧转移性结直肠癌治疗模式的专家意见
László Torday,Alinta Hegmane,Biljana Kukić et al.
László Torday et al.
Colorectal cancer (CRC) is the third most prevalent malignancy globally and the second leading cause of cancer-related mortality. Approximately 15%-30% of patients are diagnosed with metastatic CRC (mCRC), and despite increasing survival ra...